Cornelius Stephen Harlacher

1 Patent

• US121877032025

  Crystalline Forms of N -(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2 (trifluoromethyl)isonicotinamide as Raf Inhibitors for the Treatment of Cancer

  NOVARTIS AG

  0 cites